U.S. President Donald Trump on Thursday said he would soon decide whether to exclude Canadian and Mexican oil imports from ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...